1075205-27-4 Usage
Uses
Used in Pharmaceutical Industry:
2,4-Dichloro-7-(2-fluorobenzyl)-7H-pyrrolo[2,3-d]pyrimidine is used as a potential antiviral and anticancer agent due to its unique structure and properties. Its heterocyclic nature and functional groups allow for interactions with biological targets, making it a valuable molecule for the development of novel therapeutics.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2,4-Dichloro-7-(2-fluorobenzyl)-7H-pyrrolo[2,3-d]pyrimidine serves as a valuable molecule for further research and development. Its unique structure provides opportunities for the exploration of new chemical modifications and the discovery of new drug candidates with improved efficacy and selectivity.
Used in Drug Design and Optimization:
2,4-Dichloro-7-(2-fluorobenzyl)-7H-pyrrolo[2,3-d]pyrimidine can be employed as a starting point for drug design and optimization efforts. Its heterocyclic core and substituents can be modified to generate a series of analogs with varying biological activities, allowing researchers to identify the most promising candidates for further development as antiviral or anticancer drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 1075205-27-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,5,2,0 and 5 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1075205-27:
(9*1)+(8*0)+(7*7)+(6*5)+(5*2)+(4*0)+(3*5)+(2*2)+(1*7)=124
124 % 10 = 4
So 1075205-27-4 is a valid CAS Registry Number.
1075205-27-4Relevant academic research and scientific papers
Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines
Gillespie, Roger J.,Cliffe, Ian A.,Dawson, Claire E.,Dourish, Colin T.,Gaur, Suneel,Jordan, Allan M.,Knight, Antony R.,Lerpiniere, Joanne,Misra, Anil,Pratt, Robert M.,Roffey, Jonathan,Stratton, Gemma C.,Upton, Rebecca,Weiss, Scott M.,Williamson, Douglas S.
, p. 2924 - 2929 (2008/12/21)
A series of pyrazolo[3,4-d]pyrimidine, pyrrolo[2,3-d]pyrimidine and 6-arylpurine adenosine A2A antagonists is described. Many examples were highly selective against the human A1 receptor sub-type and were active in an in vivo model of Parkinson's disease.
